$EIDX: Eidos Therapeutics Announces Positive Phase 2 Data for AG10 in …

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Benzinga (https://www.benzinga.com)

Summary: 10, 2018 (GLOBE NEWSWIRE) — Eidos Therapeutics, Inc. (Eidos) (NASDAQ:EIDX), today announced positive results of its Phase 2 clinical trial studying AG10 …

Full article address: https://www.benzinga.com/pressreleases/18/11/g12675610/eidos-therapeutics-announces-positive-phase-2-data-for-ag10-in-symptom

Related News:

$EIDX: Eidos launches late-stage study of AG10 in ATTR-CM

$PG $EIDX: 12 Stocks That Pass The ‘Bollinger’ Test

$HTGC $EIDX: Hercules Capital Completes Outstanding Fourth Quarter …

$EIDX $RWGE: Is Eidos Therapeutics, Inc. (EIDX) A Good Stock To Buy?

$NTP $EIDX: Is Nam Tai Property Inc (NTP) A Good Stock To Buy?

$EIDX $MNK: Key events next week – healthcare

$EIDX: Eidos Therapeutics Receives Positive Opinion for Orphan …

$EIDX: Eidos Therapeutics to Present Phase 2 Data for AG10 in TTR …

$EIDX: FDA Grants Orphan Drug Designation to Eidos Therapeutics …

$PFE $ALNY $IONS $AKCA $EIDX $SPX: Pfizer stock drops 2% as positive rare-disease drug results won’t stop competitors

Latest News:

$AAPL: Apple Doesn’t Have Prime’s Number

$AAPL $JPM $C $ROKU $NFLX $EA: Apple Resumes Drive to $1 Trillion With Services Move Into ‘One Billion Pockets’

$AAPL: Goldman Sachs hints that Apple’s new credit card will be rolled out internationally

$MU: Samsung Sings the Chip-Making Blues

$MKC $CCL $NEOG $KBH $AAPL $GS: Apple, Samsung, McDonald’s, Uber and Careem – 5 Things You Must Know

$AXS $MMC: Insurers Creating a Consumer Ratings Service for Cybersecurity Industry

$AMZN: Don’t Just ‘Buy Now’! When Shopping on Amazon, You Need to Pay Attention

$BA: Outside the Box: Here’s how Boeing should fix its crisis management around the 737 Max

$FB: Facebook removes accounts from Russia, Iran for ‘coordinated inauthentic behavior’

$SPX: The Stock Market Is Just as Confused About a Potential Recession as You Are

$SSNLF $AAPL $MU: Samsung Warns on Q1 Profit As Weak Memory, Smartphone Demand Weighs on Chipmaker